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We examined the brains of 50 Malawian children who
satisfied the clinical definition of cerebral malaria (CM)
during life; 37 children had sequestration of infected
red blood cells (iRBCs) and no other cause of death, and
13 had a nonmalarial cause of death with no cerebral
sequestration. For comparison, 18 patients with coma
and no parasitemia were included. We subdivided the
37 CM cases into two groups based on the cerebral
microvasculature pathology: iRBC sequestration only
(CM1) or sequestration with intravascular and perivas-
cular pathology (CM2). We characterized and quantified
the axonal and myelin damage, blood-brain barrier
(BBB) disruption, and cellular immune responses and
correlated these changes with iRBC sequestration and
microvascular pathology. Axonal and myelin damage
was associated with ring hemorrhages and vascular
thrombosis in the cerebral and cerebellar white matter
and brainstem of the CM2 cases. Diffuse axonal and
myelin damage were present in CM1 and CM2 cases in
areas of prominent iRBC sequestration. Disruption of
the BBB was associated with ring hemorrhages and vas-
cular thrombosis in CM2 cases and with sequestration
in both CM1 and CM2 groups. Monocytes with phago-
cytosed hemozoin accumulated within microvessels
containing iRBCs in CM2 cases but were not present in
the adjacent neuropil. These findings are consistent
with a link between iRBC sequestration and intravascu-
lar and perivascular pathology in fatal pediatric CM,
2146resulting in myelin damage, axonal injury, and break-
down of the BBB. (Am J Pathol 2011, 178:2146–2158; DOI:
10.1016/j.ajpath.2011.01.016)
Cerebral malaria (CM) is a serious complication of Plasmo-
dium falciparum infection. Cerebral involvement occurs in
approximately 1% of infected individuals and carries a 15%
to 20% case-fatality rate, resulting in three-fourths of 1 mil-
lion to 2 million deaths/year.1 Young children in sub-Saha-
ran Africa account for 90% of CM-associated deaths. Pedi-
atric CM is a diffuse encephalopathy characterized
clinically by deep coma, often associated with clinical or
subclinical seizures in the presence of P. falciparum para-
sitemia. Most children who survive CM appear to fully re-
cover, but 10% to 20% are left with neurological disabilities,
most commonly spasticity, ataxia, hemiplegia, speech dis-
orders, and blindness2; long-term sequelae, including cog-
nitive impairment and epilepsy, are being identified with
increasing frequency in follow-up studies.3 The pathogen-
esis of coma in pediatric CM is poorly understood, and it is
not known what mechanisms determine the outcome of the
illness. Several pathogenetic mechanisms have been pro-
posed, including impaired tissue perfusion because of se-
questration of parasitized erythrocytes, immune-mediated
injury secondary to host responses to parasite products,
and cerebral edema resulting from increased permeability
of the blood-brain barrier (BBB).4–6 The relative contribu-
tions of these mechanisms to the final outcome of CM re-
main to be determined.
Previous neuropathological studies in adult patients
with CM have documented the presence of axonal injury7
and BBB dysfunction,8 in addition to the typical patho-
logical features of the disease that include adhesion and
sequestration of P. falciparum–infected red blood cells
(iRBCs) in brain microvessels, ring hemorrhages (RHs),
and Dürck’s granulomas. However, the syndrome of CM
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trapolations from one to the other regarding the patho-
physiological characteristics of severe malarial infection
are not possible. There is accumulating evidence that within
cerebral vessels, adherent iRBCs induce endothelial acti-
vation, with several consequences. These include morpho-
logical changes9 and increased expression of the endo-
thelial cell adhesion molecules inter-cellular adhesion
molecule 1 (ICAM-1), vascular cell adhesion molecule
1 (VCAM-1), and E-selectin.10–12 An associated de-
creased expression of the tight junction–associated pro-
teins occludin, vinculin, and zonula occludens protein 1
(ZO-1)13 is likely to be associated with increased permea-
bility of the BBB. These observations are supported by in
vitro studies of cultured endothelial cells derived from hu-
man brain microvessels. Exposure of such monolayers to
iRBCs leads to up-regulation of ICAM-1 expression, prob-
ably through nuclear translocation of NF-B.14 When using
similar cell cultures, both membrane-associated and solu-
ble iRBC factors can significantly reduce the barrier func-
tion of the endothelial monolayers.15 Several studies4,16–25
investigating the role of immune responses in CM have
implicated both proinflammatory [tumor necrosis factor
(TNF)-, interferon-, IL-1, and IL-6] and anti-inflammatory
(IL-10 and transforming growth factor-) cytokines and cer-
tain chemokines in disease pathogenesis; however, their
pathophysiological and immunoregulatory roles in human
CM are not fully understood.
A key issue in the pathogenesis of pediatric CM is the
nature of tissue injury that leads to severe central nervous
system (CNS) damage and death in some of the infected
children. A detailed postmortem evaluation of cerebral mi-
crovessel sequestration in fatal pediatric CM has shown the
presence of parasitized RBC sequestration in all patients
with CM and an association of sequestration with microvas-
cular pathology in 75% of these patients.26 That study fur-
ther suggested that some children with clinically diagnosed
CM actually die of other causes. The presence of malarial
retinopathy on funduscopic examination distinguished be-
tween malarial and nonmalarial coma during life.
In an attempt to better understand the pathophysiological
events in fatal CM, we performed a detailed postmortem
examination of the brains of 37 Malawian children with clin-
ically and pathologically defined CM and compared the
neuropathological findings with those in 13 cases of clini-
cally defined CM (including P. falciparum parasitemia) but
with an autopsy-identified nonmalarial cause of death and
with the findings in 18 children who died of nonmalarial
causes without evidence of peripheral parasitemia. The re-
sults of the study show that sequestration of parasitized
RBCs and microvascular pathology are associated with
extensivemyelin and axonal damage, BBB breakdown, and
glial responses in patients with fatal CM.
Materials and Methods
Patient Selection
We studied the brains of 50 Malawian children who died
of clinically defined CM at the Pediatric Research Ward,Queen Elizabeth Hospital, Blantyre, Malawi. The clinical
diagnostic criteria included the following: i) unrousable
coma [Blantyre coma score 2 (of a possible 5)] with no
improvement within 2 hours of admission, despite correc-
tion of hypoglycemia and treatment of seizures; ii) P.
falciparum parasitemia; and iii) exclusion of other clini-
cally identifiable causes of coma, including bacterial
meningitis. These patients were further subdivided into
three groups on the basis of the pathological character-
istics of the cerebral microvasculature: CM1 (n 7), CM2
(n  30), and CM3 (n  13). CM1 patients had iRBC
sequestration within cerebral microvessels without other
changes on routine histological examination of H&E-
stained sections. In the CM2 group, RBC sequestration
was associated with the presence of microvascular pa-
thology and manifested on light microscopy as intravas-
cular microthrombi and perivascular hemorrhages. There
was no history of head trauma in any of the CM1 or CM2
patients. The patients classified as CM3 had no seques-
tration of parasitized erythrocytes in cerebral vessels.
The pathological diagnoses of this group included pneu-
mococcus pneumoniae (n  2), pneumococcus pneu-
moniae and Reye’s syndrome (n  2), viral pneumonia
and Reye’s syndrome (n  2), hepatitis (n  1), hepatic
necrosis (n  1), giant-cell myocarditis (n  1), ruptured
arteriovenous malformation (n  1), subdural and intra-
cerebral hematomas (n  1), severe anemia (n  1), and
cerebral edema, likely secondary to septicemia or hypo-
glycemia (n 1). CM3 patients represented a cohort with
CM symptoms but without malarial cerebral disease and
only with incidental parasitemia. We added to this group
a second cohort of 18 patients with CM symptoms but
without CM and without parasitemia. These patients died
of illnesses causing coma, had no peripheral para-
sitemia, and were described as “coma of other cause”
(COC). These included bacterial or tuberculous meningi-
tis (n  3), viral encephalitis and Reye’s syndrome (n 
1), sepsis (n  4), sepsis and Reye’s syndrome (n  1),
bacterial meningitis and Reye’s syndrome (n 1), Reye’s
syndrome (n 3), salicylate toxicity (n 1), organophos-
phate toxicity (n  1), acute renal failure (n  1), small-
bowel obstruction (n 1), and coma of unknown etiology
(n  1). Testing for HIV was performed in all cases
using two rapid tests (Determine and Unigold). Discor-
dant results would be addressed via PCR, but there
were no discordant results in this series. In all cases,
the patient was discovered to be HIV positive after
admission to the research ward. None of these patients
was receiving antiretroviral therapy at admission.
We performed a complete autopsy on all patients in the
mortuary of Queen Elizabeth Hospital using a standard-
ized dissection and collection protocol, after obtaining
informed consent from the families of the deceased. The
study was approved by the ethics committees of the
College of Medicine, University of Malawi, Blantyre, Ma-
lawi; Michigan State University, East Lansing, MI; Univer-
sity of Liverpool, London, UK; and University of British
Columbia, Vancouver, BC, Canada. At each autopsy, the
brains were removed, photographed, weighed, exam-
ined, and sectioned in the fresh state. Representative
sections from the frontal, parietal, temporal, and occipital
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pons; medulla; and cerebellum were fixed in 10% buff-
ered formalin and embedded in paraffin. For analytical
purposes, we grouped the representative sections as
follows: white matter and gray matter from cerebral hemi-
spheres (frontal, parietal, temporal, and occipital lobes
and hippocampus), subcortex (caudate nucleus and
thalamus), brainstem (midbrain, pons, and medulla), and
cerebellum (tonsils and dentate nucleus).
Neurohistological Characteristics and
Immunohistochemistry
Sections, 6-m thick, were stained with H&E and Luxol
fast blue/H&E. Sections, 3-m thick, were stained with
the indirect immunoperoxidase technique for the follow-
ing: i) -amyloid precursor protein (-APP; 22C11, 1:500,
mouse monoclonal; Chemicon, Temecula, CA) for the
detection of axonal injury; ii) fibrinogen (1:500, rabbit
polyclonal; Dako, Carpinteria, CA) for the assessment of
BBB disruption; iii) glial fibrillary acidic protein (1:2000,
rabbit polyclonal; DAKO) for the assessment of gliosis; iv)
CD45 (2B11PD7/26, 1:100, mouse monoclonal; DAKO),
CD68 (KP1, 1:60, mouse monoclonal; DAKO), CD8 (C8/
144B, 1:80, mouse monoclonal; DAKO), and CD4 (1F6,
1:50, mouse monoclonal; NoVoCASTRA, Newcastle upon
Tyne, UK) for the demonstration of leukocytes, mono-
cytes, and CD8 and CD4 T lymphocytes, respectively;
and v) CR3/43 (1:300, mouse monoclonal; DAKO) for the
demonstration of class II major histocompatibility mole-
cules (MHCs). Sections were deparaffinized by heating
at 37°C overnight, then 60°C for 30 minutes, followed by
three changes in xylene, two changes in 99% ethanol,
one change in 95% ethanol, and several changes in
water. Microwave antigen retrieval was performed in 10
mmol/L sodium citrate buffer for fibrinogen, -APP,
CD45, and CD68. Tris/EDTA buffer was used for CD8 and
CD4 staining. After blocking the endogenous peroxidase,
sections were incubated with 5% bovine serum albumin
in Tris–Tween 20 buffer at room temperature for 30 min-
utes and incubated with the primary antibodies for 60
minutes (fibrinogen) or 90 minutes (glial fibrillary acidic
protein, -APP, CD45, and CD68) or overnight at 4°C
(CD8 and CD4). After washing in Tris–Tween 20 buffer,
sections were incubated for 1 hour with the secondary
antibodies (goat anti-mouse or goat anti-rabbit IgG con-
jugated to horseradish peroxidase) at a 1:500 dilution,
incubated in 3-amino-9-ethylcarbazole, and counter-
stained with hematoxylin. Negative controls included
omission of primary antibodies and sections of age-
matched normal brain specimens obtained from the De-
partment of Pathology, BC Children’s Hospital (Vancou-
ver, BC, Canada). In the -APP–stained sections, positive
immunoreactivity of neuronal perikarya served as the
positive control. Paraffin sections of tonsils or lymph
nodes served as positive controls for CD4, CD8, CD45,
CD68, and class II MHC staining.Quantitative Evaluation of Neuropathological
Findings
We quantified RHs by counting the number of hemor-
rhages in 10 randomly selected fields in each of the 12
sections with a microscope (Nikon Labophot) at 10
magnification using a 1-cm2 ocular grid. Myelin and
axonal damage was similarly quantified by counting
the number of white matter areas with myelin pallor and
vacuolation and the number of foci with -APP–positive
swollen axons, with and without associated RHs in 10
randomly selected fields, in each section at 10 magni-
fication. In addition, the size of the areas with myelin or
axonal damage was measured using the same 1-cm2
ocular grid at 10 magnification and expressed as mi-
crometer squared areas of myelin or axonal damage per
10 fields. Quantification of fibrinogen leakage was per-
formed by counting the number of leaky vessels in 10
randomly selected fields in the gray and white matter in
each section at 10 magnification. Gliosis was quan-
tified by counting the number of reactive astrocytes in
10 randomly selected fields in each section at 20
magnification using the ocular grid. The identity of the
slides was masked before counting, so that all counts
were performed by readers (authors K.S. and H.H.;
and Farrah Samadi-Bahrami) who were unaware of the
patient’s clinical or pathological diagnoses.
Statistics
The four patient groups were described at baseline
and had their characteristics compared through 2 and
Fisher’s exact tests when studying categorical mea-
sures and analysis of variance or the Kruskal-Wallis
test when studying continuous measures. When appro-
priate, logarithmic transformations were performed
and geometric means were estimated.27 We were par-
ticularly interested in comparisons of CM1 with CM2
and with patients without malarial cerebral disease
(CM3 and COC) because we wanted to identify alter-
ations particular to malarial disease.
To characterize brain damage using previously de-
scribed pathological counts, we summarized all count
variables using medians of 10 randomly selected fields of
each of the 12 brain areas: white and gray matter from
cerebral hemispheres (frontal, parietal, temporal, and oc-
cipital lobes and hippocampus), subcortex (caudate and
thalamus), brainstem (midbrain, pons, and medulla), and
cerebellum (tonsils and dentate nucleus). Medians were
estimated for each CM class separately, focusing on
comparisons of CM1 and CM2 counts between brain
regions.
Results
The patients in the four histopathologically defined
groups (CM1, CM2, CM3, and COC) were essentially
similar in age, duration of illness before and after admis-
sion, depth of coma on admission, and postmortem in-
terval (Table 1). The CM1 and CM2 patients had, on
e used
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on admission compared with patients with nonmalarial
cerebral disease (CM3 and COC). Results were essen-
tially similar when the group of patients with nonmalarial
cerebral disease was separated into CM3 and COC and
comparisons were performed of CM1 versus CM2 versus
either CM3 or COC. For instance, the P value of the
Fisher’s exact test comparing the four groups of patients
on HIV-positive status was 0.23.
Gross Pathological Features
Gross examinations of the brains were performed in the
fresh state. The brain weights were compared with the
average normal brain weights of age-matched white chil-
dren28 because there are no published data on normal
brain weights of African children. The brain weight of 21
of 30 CM2 cases was variably increased up to 32%
higher than the normal weight (Figure 1). Of the remain-
Table 1. Clinical and Demographic Features
Variable
CM1
(n  7)
Age (months) 56
Male sex (%) 29
HIV positive (%) 43
Blantyre Coma Score on admission 1.43
Admission parasitemia (geometric mean) 56,629
Coma duration before admission (hours) 7.20
Time to death (hours) 16.00
Autopsy interval (hours) 7.33
Data are given as mean unless otherwise indicated. P values were est
plus the COC group, except when comparing parasitemia because, by d
sex and HIV, we used the Fisher’s exact test. For admission parasitemia, w
to death, and autopsy interval, we used analysis of variance.
Figure 1. Brain weights of children in the CM1, CM2, CM3, and COC groups
compared with the normal brain weights of age-matched white children. The
brain weights of most children in the CM1, CM2, and, to a lesser extent, CM3
groups are higher than the normal values. CI indicates confidence interval.ing CM2 cases, seven had normal and two had slightly
below normal brain weights. Among the seven CM1 pa-
tients, six had increased brain weights up to 51% above
normal and one had a brain weight that was within normal
limits. Of the 13 CM3 cases, eight had increased brain
weights up to 27% higher than the normal range. In 14 of
the 18 COC cases, the brain weight was increased; in
Figure 2. A andB: Coronal sections through the cerebral hemispheres of a CM2
patient. A: Numerous petechial hemorrhages are distributed throughout the white
matter. The lateral and third ventricles are compressed because of edema. B:
Close-up view of hemorrhages in the white matter. The gray matter is largely
spared.C throughG:Vascular changes in CM2 patients.C: The lumen of all small
vessels in the field is distended by sequestered iRBCs. D: Some microvascular
endothelial cells are hypertrophic and display large vesicular nuclei (arrow-
heads). E: A small branching vessel in the white matter contains iRBCs and
hemozoin. One of the branches (arrow) is occluded by thrombus, is partially
denuded of endothelial cells, and is associated with an RH. In the adjacent
branch with iRBC sequestration, hypertrophic endothelial cells display
large nuclei (arrowhead). F and G: RHs in the cerebral white matter
correspond to petechial hemorrhages in A and B. G: Small, often throm-
bosed, ruptured capillaries containing iRBCs are immediately surrounded
by a zone of necrosis that, in turn, is surrounded by a ring of extravasated
RBCs, a few white blood cells, and extraerythrocytic pigment granules. C
2
30)
CM3COC
(n  31) P value
CM3
(n  13)
COC
(n  18)
41 0.49 33 48
45 0.19 69 28
15 0.19 8 20
.97 0.90 0.20 0.69 1.06
5450 0.02 5450 0
.36 10.00 0.65 5.50 5.50
.87 28.21 0.13 29.38 27.36
.81 7.91 0.63 7.27 8.37
or comparisons of the CM1 group versus the CM2 group versus the CM3
atients in the COC group did not have parasitemia. When comparing for
the Kruskal-Wallis statistic. For age, coma at and before admission, timeCM
(n 
42
63
13
0
73,369
11
13
6
imated f
esign, pthrough G: H&E staining. Scale bars: 25 m (C and D); 50 m (E and G);
100 m (F).
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case, the brain weight was lower than normal. There was
a variable degree of flattening of the gyri and narrowing
of the sulci in patients with brains of increased weight.
Among the children with a significantly increased brain
weight, mild tonsillar and/or uncal herniation was ob-
served in 10 (six in the CM2, two in the CM1, one in the
CM3, and one in the COC group). Coronal sections of the
brains of all CM2 patients showed the presence of nu-
merous petechial hemorrhages widely distributed in the
white matter of the cerebral hemispheres (Figure 2, A and
B), in the brainstem, and in the white matter of the cere-
bellum, including the cerebellar folia.
Histopathology—Sequestration and
Microvascular Pathology
In both CM1 and CM2 patients, most microvessels in the
gray and white matter contained sequestered iRBCs (Fig-
ure 2C). In larger pial and subarachnoid vessels, iRBCs
were adherent to the endothelium without occupying the
entire lumen. Independent of the presence or absence
of iRBC sequestration, microvessel endothelial cells
often appeared hypertrophic, with prominent vesicular
nuclei (Figure 2D). Sequestration in the CM2 group
was frequently associated with fibrin–platelet thrombi
and intravascular accumulation of pigment–containing
monocytes (Figure 2E). Microvascular thrombosis was
often associated with necrosis of the endothelial lining
of the occluded vessel and perivascular hemorrhage
(Figure 2E).
Perivascular RHs, characterized by a central, often
thrombosed, ruptured capillary containing iRBCs and
surrounded by a zone of necrosis with an outer ring of
extravasated nonparasitized RBCs and a few white blood
cells, were a feature of CM2, but not (by definition) of
CM1, patients (Figure 2, F and G). In the cerebral hemi-spheres, these hemorrhages invariably occurred in the
white matter, with extension to the gray–white matter
junction, but were rare in the cortical and subcortical gray
matter. RHs were most numerous in the cerebral hemi-
spheres, brainstem, and cerebellum, followed by the
subcortex (Figure 3A). There was no sequestration and
no intravascular or perivascular pathological features in
the CM3 and COC groups.
Myelin and Axonal Injury
Myelin damage was assessed in sections stained with
Luxol fast blue/H&E. Two different types of myelin dam-
age were observed. The first type was characterized by
discrete areas of total myelin loss in the necrotic perivas-
cular zone of RHs (Figure 4A). The second type con-
sisted of patchy, poorly defined, irregular, diffuse, and
variably sized foci of myelin pallor and vacuolation asso-
ciated with prominent sequestration of iRBCs within cap-
illaries at the center of these foci (Figure 4, B and C).
Neither of these lesions was associated with phagocyto-
sis of myelin by macrophages. RH–associated myelin
loss was a feature of CM2 cases and followed the distri-
bution of RHs (Figure 3B). Areas of diffuse myelin dam-
age were present in both the CM1 and CM2 groups.
These areas were distributed in the white matter of the
cerebral hemispheres and cerebellum and in the white
matter tracts of the subcortex and brainstem in the CM2
group but were found only in the white matter of the
cerebral hemispheres, subcortex, and brainstem in the
CM1 group (Figure 5A). The largest areas of diffuse my-
elin damage were observed in the cerebral hemispheres
and cerebellum of the CM2 cases and the smallest areas
in the brainstem. In the CM1 cases, the largest areas of
myelin pallor and vacuolation were in the brainstem and
the smallest areas were in the white matter of the cerebral
hemispheres. Diffuse myelin damage was the most com-
mon type of myelin pathology and was found even in
Figure 3. Quantification of RHs (A) and RH-
associated findings (B–D) in the CM1 (shaded
circles) and CM2 (unshaded circles) groups. A:
The RHs are present only in the CM2 group and
are most numerous in the cerebral white matter,
followed by the cerebellar white matter, brains-
tem, and fiber tracts of the subcortical gray mat-
ter. In the cortex, RHs occur at the gray-white
matter junction. B: RH-associated myelin dam-
age is confined to the CM2 group and follows
the distribution of RHs, being most frequent in
the cerebral white matter and gray-white matter
junction, followed by the cerebellar white matter
and the fiber tracts of the subcortical gray matter
and brainstem. C: RH-associated axonal injury
occurs only in the CM2 group, follows the dis-
tribution of RHs, and is most prevalent in the
cerebral and cerebellar white matter and the fi-
ber tracts of the subcortical gray matter, followed
by the brainstem. D: Fibrinogen extravasation in
association with RHs is confined to CM2 cases,
follows the distribution of these hemorrhages,
and is most prevalent in the cerebral white mat-
ter, followed by the cerebellum, subcortex, and
brainstem. hpf indicates high-power field.
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was not present in either CM3 or COC cases. Occasional
small foci of diffuse myelin pallor were found in the cere-
bral white matter and rarely in the brainstem and cere-
bellum of a few CM3 cases but not in the COC group.
Axonal injury was assessed by staining sections with
the indirect immunoperoxidase technique for –APP, an
axonally transported protein that accumulates within in-
jured axons as a result of disruption of the fast axonal
transport in various CNS disorders. It is a reliable, sensi-
tive, and early marker for axonal injury that can be de-
Figure 4. Myelin damage in pediatric CM. A: Myelin pallor and fragmenta-
tion has occurred in association with an RH surrounding a thrombosed and
disrupted parasitized microvessel in the cerebral white matter. B: Irregular,
ill-defined, and variably sized foci of diffuse myelin vacuolation and pallor
unassociated with RHs typically occur in the CM2 and, to a lesser extent, CM1
groups. C: Areas of diffuse myelin damage encompass several distended
microvessels filled with iRBCs (arrows). Luxol fast blue/H&E staining. Scale
bars: 50 m (A); 100 m (B and C).tected within 2 to 3 hours29,30 and as early as 35 minutesafter injury.31 Axonal -APP is not detectable in the nor-
mal brain by routine IHC of FFPE sections. Three distinct
types of axonal injury were observed. The first type was
associated with RHs in CM2 patients and consisted of
variably sized clusters of intensely -APP–immunoreac-
tive swollen and disrupted axons with axonal spheroid
formations immediately adjacent to the hemorrhage (Fig-
ure 6A). The number of hemorrhage-associated -APP–
positive axons varied even within the same section. Some
RHs were associated with only occasional abnormal ax-
ons, suggesting a 1-hour interval between the occur-
rence of the hemorrhage and death (Figure 6B). The
distribution of this type of axonal damage followed that of
RHs, being most prevalent in the white matter of the
cerebral hemispheres, followed by the fiber tracts of the
subcortex and the cerebellar white matter, and least
common in the brainstem (Figure 3C). The second type of
axonal injury consisted of patchy, ill-defined, irregular,
discrete or confluent, variably sized collections of closely
packed strongly -APP–positive tortuous axons with var-
icosities and focal swellings along their course. These
areas of axonal injury were not associated with hemor-
rhage and were randomly distributed in the white matter
of the cerebral and cerebellar hemispheres (Figure 6,
C–F) and in fiber tracts of the basal ganglia, thalamus,
pons (Figure 6G), midbrain, and medulla (Figure 6H) in
CM1 and CM2 patients. This type of diffuse axonal dam-
age was often associated with capillaries packed with
sequestered iRBCs in the center of the lesion (Figure 6, F
and G). Diffuse axonal injury was not evenly distributed in
the CNS and was most frequent in the cerebral hemi-
spheres, brainstem, and cerebellum and least frequent in
the subcortex. The largest areas of diffuse axonal dam-
age were in the cerebral and cerebellar white matter,
whereas the smallest foci were present in the medulla
(Figure 5B). Diffuse axonal damage was not confined to
CM2 cases but was also present in CM1 cases, although
both the number and size of these lesions were smaller in
CM1 than in CM2 cases (Figure 5B). Some CM3 cases
showed infrequent, single, -APP–positive axons scat-
tered in the white matter tracts of the brainstem. Diffuse
axonal damage was the most frequent type of axonal
injury and was present even in cases with few or no RHs.
Axonal damage was not present in the COC group of
patients. The third type of axonal damage was charac-
terized by small discrete foci of -APP immunoreactivity
immediately adjacent to a capillary containing parasit-
ized RBC and fibrin-platelet thrombi (Figure 6, I and J)
without an associated RH. This was the least common
type of axonal injury and was observed only in CM2
patients. In sections double stained for -APP and Luxol
fast blue, diffuse myelin damage often coincided with
diffuse axonal injury; however, there were areas of myelin
loss devoid of -APP–positive axons (Figure 6, K and L).
In contrast, axonal injury was invariably associated with
myelin changes.
BBB Permeability
The permeability of the BBB was assessed by immuno-
staining sections for fibrinogen, a 340,000 mol.wt. serum
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intact BBB.32 In CM, increased permeability of the BBB
was usually, but not exclusively, associated with specific
vascular pathological features, so that three patterns of
BBB breakdown could be distinguished. The first pattern
was characterized by fibrinogen extravasation in associ-
ation with RHs (Figure 7A) and was confined to the white
matter of the cerebral hemispheres, subcortex, brains-
tem, and cerebellum in the CM2 cases (Figure 3D). The
second pattern consisted of fibrinogen leakage around
microvessels occluded by fibrin thrombi (Figure 7B) in
the white matter and, to a lesser extent, the gray matter of
the cerebral hemispheres, brainstem, and cerebellum in
CM2 patients. In the third type of BBB breakdown, fibrin-
ogen was deposited around blood vessels with promi-
nent RBC sequestration but without fibrin thrombi, in both
CM1 and CM2 patients, following the same distribution as
the second type of lesions (Figure 5C and Figure 7, C and
D). In addition, scattered leaky vessels without associ-
ated vascular pathological features were present in all
CM1 and CM2 cases. Focal extravasation of fibrinogen
across cortical and white matter microvessels was also
observed in the CM3 and COC groups, without associ-
ated vascular wall changes or intravascular pathology.
When the overall number of leaky vessels was consid-
ered, there were no significant differences in BBB disrup-
tion among the four groups of patients. However, the
number of permeable parasitized vessels in the subcor-
tex and brainstem was greater in the CM2 than the CM1
cases (Figure 5C). The number of vessels permeable to
fibrinogen was greater in the white matter than in the gray
matter in all patient groups, with the exception of the COC
patients, in whom no significant differences were found.
Cellular Immune Responses
A consistent finding in all malaria cases was the absence
of an extravascular localized immune response to the
vascular, myelin, and axonal pathology. Dürck’s granu-lomas, which consist of collections of reactive microglia,
astrocytes, and lymphocytes, were not present in any of
the 37 cases of CM. Dürck’s granulomas are a feature of
adult CM and probably represent a later immune re-
sponse to focal parenchymal necrosis. A variable num-
ber of CD45/CD68-positive monocytes containing hemo-
zoin were present in the lumen of microvessels in the gray
and white matter of the cerebral hemispheres, subcortex,
brainstem, cerebellum, and leptomeninges of CM2 pa-
tients. Microvessels were often distended by the accu-
mulated monocytes, which appeared to occupy most of
the lumen of capillaries and venules but did not migrate
out of the vessels into brain tissue (Figure 8, A, C, and D).
Often, a capillary lumen was completely filled with a (pre-
sumably adherent) monocyte (Figure 8, A, C, and D).
Monocytes with phagocytosed malarial pigment were usu-
ally present, along with extravasated RBCs, in the center of
RHs (Figure 8B). Neither CD4 nor CD8 T lymphocytes
were found in areas of RH, myelin, or axonal damage in
CM1 or CM2 cases; and only occasional CD8 T cells were
observed within the vascular lumen and, infrequently, in the
subendothelial region of a few blood vessels in one CM1
and three CM2 cases. Scattered perivascular chronic in-
flammatory cell infiltrates were present in the brain paren-
chyma in some of the infectious CM3 cases. Occasional
microglial cells expressing class II MHC molecules were
seen in a few CM2 cases. Among the HIV-positive children,
we did not observe pathological changes of HIV encepha-
litis or opportunistic infections.
Astrocytic Responses
We assessed the presence, severity, and distribution of
gliosis in sections immunostained for glial fibrillary acidic
protein. There was diffuse proliferation of reactive astro-
cytes in the subcortical and deep white matter of the
cerebral hemispheres and cerebellum and along fiber
tracts in the basal ganglia, thalamus, and brainstem in all
Figure 5. Quantification of non–RH-associated
damage in the CM1 (shaded circles) and CM2
(unshaded circles) groups. A: Areas of diffuse
myelin damage are present predominantly in
CM2 and, to a much lesser extent, CM1 patients
and are only occasionally found in the nonma-
larial groups. B: Diffuse axonal injury is present in
both CM2 and CM1 patients, with only occasional
small lesions seen in the CM3 and COC groups.
The largest areas of axonal damage occur in the
cerebral and cerebellar white matter, followed by
the subcortex and brainstem. C: Increased perme-
ability to fibrinogen, independent of RHs or
thrombosis, is present in the two malaria groups
(CM1 and CM2), with no significant differences
between the two groups. D: Reactive astrocytes
are present in the subcortical and deep white
matter of all brain regions examined in both CM1
and CM2 patients. Compared with the CM1 class,
the CM2 group exhibits a greater degree of gli-
osis in the cerebral white matter. hpf indicates
high-power field.CM1 and CM2 cases. Reactive astrocytes were not found
uestratio
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in a few cases. The degree of astrogliosis varied among the
CM cases, frommild to moderate, and did not correlate with
RBC sequestration or myelin or axonal damage. There was
no spatial association between gliosis and either RHs or
areas of axonal or myelin changes. Reactive astrocytes
were present at a similar density in and around patches
Figure 6. Patterns of axonal damage in pediatric CM detected by -APP IHC.
and disrupted axons in an RH around a thrombosed and ruptured white ma
RHs. C through H: Diffuse axonal injury in CM2 patients. Confluent (C) or sin
and cerebellar white matter (C, E, and F), the gray-white matter junction (D),
(F and G, arrows). H: Smaller diffuse lesions are evident in the medulla. I
to capillaries occluded by iRBC with (I) or without (J) a thrombus. In sectio
often (K), but not invariably (L), coincide in areas with prominent iRBC seq
K, and L).of axonal and myelin lesions (Figure 9A) and RHs (Figure9B) as they were in the white matter that appeared unin-
volved. Gliosis was not a unique feature of CM because
all COC cases and 10 of the 13 CM3 cases showed
comparable astrocytic responses. However, when com-
paring the different groups, gliosis was more prominent in
the cerebral white matter of CM2 versus CM1 patients
(Figure 5D) and in the cerebral white matter and brains-
: RH-associated axonal damage. A: Strongly -APP–immunoreactive swollen
llary. B: Only a few -APP–positive axons are present in the center of some
ill-defined irregular patches of -APP–immunoreactive axons in the cerebral
s (G). Diffuse axonal damage occurs in areas with heavy iRBC sequestration
all discrete foci of -APP–positive axons are present immediately adjacent
le stained for -APP and Luxol fast blue, diffuse axonal and myelin lesions
n (arrows). Scale bars: 50 m (A, B, and F–J); 250 m (C); 100 m (D, E,A and B
tter capi
gle (D)
and pon
and J: Sm
ns doubtem of CM1 and CM2 cases than in the CM3 group.
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In this study, we describe the brain pathological fea-
tures in a large series of Malawian children dying of
CM. We compare the neuropathological findings with
those in children who met the standard case definition
of CM during life but had no evidence of parasite
sequestration in the cerebral microvasculature and
had a nonmalarial cause of death identified at autopsy.
As a further comparison group, we included children
without malarial infection, who died with COC. Patients
with clinically defined CM were classified into three
groups based on the cerebral histological appearance
on light microscopy: presence of sequestration of iR-
BCs only (CM1), sequestration with intravascular and
perivascular pathology (CM2), and absence of se-
questration (CM3).
Figure 7. Patterns of BBB disruption detected by fibrinogen IHC. A:
Fibrinogen extravasation occurs in association with ruptured capillaries
and RHs. B: Fibrinogen has extravasated across a microvessel occluded by
thrombus. C and D: Increased permeability of the BBB to fibrinogen in
microvessels with heavy iRBC sequestration occurs without thrombosis or
hemorrhage in the white (C) and gray (D) matter. Scale bar  50 m
(A–D).
Figure 8. Immunohistochemical demonstration of intravascular monocytes
in the CM2 group. Monocytes with phagocytosed extraerythrocytic pigment
fill and distend the lumen of many small vessels in the cortex (A), pons (C),
and medulla (D). Although adherent to the endothelium (A, inset), mono-
cytes do not transmigrate across the BBB to infiltrate the neuropil. The lumen
of several capillaries (A, C, and D) is occluded by adherent monocytes.
B: Monocytes, along with pigment and RBCs, have been released from the
vascular lumen in an RH. Stainings: CD68 (A and B); CD45 (C and D). Scale
bars: 50 m (A–D); 2 m (inset).On gross examination, a mild to moderate increase of
brain weight was present in 6 (86%) of the CM1 cases, 21
(70%) of the CM2 cases, and 8 (62%) of the CM3 cases.
The contribution of cerebral edema to the pathophysio-
logical features and clinical outcome of CM is not well
understood. Increased intracranial pressure (identified
by computed tomography) and postmortem brain edema
have been reported in African children with CM and are
associated with poor prognosis.33–35 In addition, some
children with severe intracranial hypertension had wide-
spread low-density areas on computed tomographic
scans, suggestive of ischemic damage.36 In contrast,
postmortem studies37 of adult patients with CM have
shown the presence of cerebral edema in a few patients
and do not support a direct link between brain swelling
and fatal outcome. Several factors may contribute to ce-
rebral edema, including RHs and increased permeability
of the BBB. In view of differences in the pathological
findings among our four patient groups, it is likely that
more than one mechanism is responsible for the patho-
genesis of cerebral edema in these patients.
All CM2 cases showed, by definition, significant vas-
cular pathology in the form of iRBC sequestration in as-
sociation with the presence of intraerythrocytic pigment
and pigment granules in macrophages, RHs, and focal
occlusion of the parasitized microvessels by fibrin-plate-
let thrombi. RHs, a pathological hallmark of CM, were
Figure 9. Reactive gliosis in CM detected by glial fibrillary acidic protein
IHC. A: Mild diffuse gliosis in and around an area of myelin pallor and
vacuolation and prominent iRBC sequestration. B: Diffuse gliosis in the
neuropil around an RH. Scale bar  100 m (A and B).present only in the CM2 cases and were most frequent in
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a lesser extent, in the basal ganglia, thalamus, and brain-
stem. They surrounded heavily parasitized and often
thrombosed microvessels that exhibited segmental loss
of endothelial cells. These findings suggest that RHs are
the result of irreversible endothelial damage and necro-
sis, leading to abrupt disruption of the endothelial lining
and subsequent extravasation of nonparasitized RBCs,
pigment globules, and macrophages. In the absence of
local thrombosis, endothelial cells of parasitized vessels
appeared normal or displayed large vesicular nuclei sug-
gestive of activation.
Morphological alterations of brain endothelium at the
site of iRBC sequestration have been described.9 Several
studies38 provide evidence of endothelial activation and
up-regulation of adhesion molecules, such as ICAM-1,
VCAM-1, E-selectin, platelet endothelial cell adhesion
molecule 1 (PECAM-1), thrombospondin, and chondroitin
sulfate, that have been implicated in the cytoadherence
of P. falciparum to the endothelium. In a recent study,39
coincubation of human brain endothelial cell monolayers
with P. falciparum–infected erythrocytes for 6 hours re-
sulted in up-regulation of the NF-B signaling pathway,
induction of ICAM-1, and up-regulation of chemokines,
cytokines, proapoptotic and antiapoptotic proteins, and
genes related to the immune response. Although the
exact mechanisms involved in the activation of the cere-
bral endothelium in our cases are not known, it is possible
that contact-dependent or soluble parasite factors and
circulating cytokines play a role. Under normal condi-
tions, the vascular endothelium has a nonthrombogenic
luminal surface that resists platelet adhesion and throm-
bosis. Exposure of endothelial cells to certain inflamma-
tory mediators, such as IL-1 and TNF-, induces pro-
coagulant activity and tissue factor production and
suppresses fibrinolytic activity.40–43 It is likely that in CM,
several factors, including circulating cytokines, locally
released IL-1 and TNF-, and mediators released from
iRBCs or after iRBC lysis, act on the BBB endothelium to
induce prothrombogenic changes on the luminal surface.
The formation of fibrin thrombi, often in association with
focal loss of endothelial cells and with RHs, suggests that
there are critical alterations of endothelial function that
could lead to irreversible endothelial damage. These ob-
servations are consistent with the results of recently re-
ported in vitro studies that suggest that direct contact with
iRBCs induces endothelial apoptosis through a caspase-
dependent pathway44 and that some P. falciparum strains
are more apoptogenic than others.45 A pathogenic role
for platelets in endothelial damage has also been sug-
gested in recent studies46 showing that platelets poten-
tiate the cytotoxic effect of iRBCs on brain endothelial
cells through direct contact with the endothelium. The P.
falciparum–associated molecules that induce endothelial
activation versus apoptosis and the mechanisms in-
volved are also not known.
RH-associated myelin and axonal damage was a
prominent and constant finding in all CM2 cases. Physi-
cal damage of the myelin sheaths and axons, secondary
to sudden disruption of the vessel wall and hemorrhage,
seems to be the most likely pathogenetic mechanism.Not uncommonly, the area with myelin pallor and vacuo-
lation surrounding RHs contained few, if any, -APP–
immunoreactive axons. Because -APP IHC detects ab-
normal axons as early as 35 minutes after injury, the
presence of RHs with myelin damage and only a few or
no -APP–positive axons suggests that these hemor-
rhages occurred shortly before death. Diffuse myelin and
axonal damage in CM2 and CM1 cases occurred in ar-
eas with prominent iRBC sequestration in white matter
capillaries and venules. Although close proximity of some
of these areas to RHs in the CM2 cases cannot be entirely
excluded, the size, shape, and distribution of these le-
sions strongly suggest that they are likely the result of
anoxic injury secondary to microvascular occlusion by
sequestered iRBCs and/or fibrin-platelet thrombi. This is
supported by the presence of minute discrete axonal
lesions immediately surrounding thrombosed capillaries
and by the fact that diffuse axonal and, to a lesser extent,
myelin damage was found in all CM1 cases in which RHs
were entirely absent. Although diffuse myelin and axonal
damage often coincided, the acute nature of these le-
sions, as indicated by the absence of reactive changes,
suggests that they occurred independently of each other.
To what extent the diffuse multifocal myelin and axonal
lesions are reversible or permanent and associated with
either a fatal outcome or neurological and cognitive def-
icits in the surviving patients is unknown. A somewhat
different type of axonal injury was previously identified in
adult Vietnamese patients dying of CM.7 Similar foci of
myelin and axonal damage can be seen in acute dissem-
inated encephalomyelitis and as small perivascular le-
sions in intravascular lymphoma of the CNS around mi-
crovessels occluded by neoplastic lymphocytes.
Disruption of the BBB was present in all four patient
groups and was associated with a different type of vas-
cular pathology in each group of patients. Increased
permeability to fibrinogen around RHs and thrombosed
microvessels was a unique feature of CM2 patients. This
type of BBB disruption is obviously secondary to irrevers-
ible endothelial damage and loss of the endothelial lining
of the involved vessels and is likely one of the mecha-
nisms contributing to cerebral edema. In both CM1 and
CM2 cases, extravasation of fibrinogen occurred across
several heavily parasitized microvessels without associ-
ated overt disruption of the endothelial lining. In the CM3
and COC cases, the increased permeability of the BBB
was randomly distributed and was not associated with
any specific vascular pathology. Previous postmortem
studies47 in eight Malawian children with CM showed
focal loss of immunostaining for the endothelial tight junc-
tional proteins ZO-1, occludin, and vinculin that spatially
coincided with the presence of sequestered iRBCs in
small vessels but was not associated with fibrinogen ex-
travasation around these vessels. Studies in adult Viet-
namese patients with CM by some of the same research-
ers4 showed similar changes in the distribution of junctional
proteins and, in addition, leakage of plasma proteins across
cerebral microvessels.
The mechanisms responsible for the dysfunction of the
BBB in pediatric CM have not been fully elucidated. The
adhesion of sequestered iRBCs to cerebral endothelium
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hypothesis is supported by in vitro studies. These studies
show decreased mRNA levels for tight junction proteins in
endothelial cell monolayers co-cultured with iRBCs fromCM
patients48 and decreased transendothelial electrical resis-
tance of human brain endothelial cell monolayers on direct
contact with P. falciparum iRBCs or P. falciparum iRBC cul-
ture supernatants, suggesting the involvement of both
contact-dependent and contact-independent factors.15
Cytokines, either locally or systemically released by ac-
tivated macrophages, may further contribute to the in-
creased permeability of the BBB. Incubation of human
brain endothelial cell cultures with TNF-, interferon-, or
IL-1 induces morphological changes associated with
increased permeability to horseradish peroxidase and
decreased transendothelial electrical resistance across
the monolayers.49,50 The production of these cytokines
by monocytes and CD4 T lymphocytes in response to
iRBC and malarial pigment has been documented in
CM51,52 and may, at least in part, account for the in-
creased permeability of the BBB in microvessels, with
prominent sequestration in CM1 and CM2 cases and in
CM3 and COC cases with an infectious etiology.
Invasion of the brain by T cells and macrophages and
localized extravascular cellular immune responses were
uniformly absent in CM1 and CM2 patients. The presence
of hemozoin-laden monocytes within the lumen of small
cerebral blood vessels was invariably associated with
intravascular and perivascular pathology and further dis-
tinguished the CM2 group from the other patient groups.
Although monocytes aggregated and adhered to the lu-
minal surface of the endothelium, they remained intravas-
cular and did not migrate across the vessel wall to enter
the brain parenchyma. The only exception was the few
extravasated monocytes in association with RHs. Mono-
cyte adhesion to cerebral endothelium is mediated by
interactions between ICAM-1 and VCAM-1, which have
been shown to be up-regulated in CM,10,11,53 and their
corresponding ligands on monocytes, macrophage-1 an-
tigen (MAC-1) (CD11/CD18), and VLA4 (4/1).54
ICAM-1 is a key molecule in the adhesion cascade and
mediates both adhesion and transendothelial migra-
tion.55 Therefore, it is intriguing that hemozoin-laden
monocytes are found only within the microvessel lumen
and do not appear to have migrated through or beyond
the vessel wall. Experimental studies have shown that
uptake of hemozoin results in both down-regulation of
certain monocyte functions, such as class II MHC and
integrin expression, oxidative burst, and repeat phago-
cytosis; and up-regulation of other functions, including
the production of metalloproteinase 9, chemokines, and
cytokines.56 Phagocytosis of hemozoin and iRBC could
potentially initiate intracellular events that would interfere
with the formation of actin-rich filopodia, resulting in the
inability of adherent monocytes to transmigrate. Alterna-
tively, hemozoin and/or factors released from ruptured
iRBCs may act on endothelial cells to inhibit “outside-in”
signaling after ICAM-1 ligation and the formation of stress
fibers, which are essential for cell migration.57 Increased
serum levels of the monocyte-produced macrophage mi-
gration inhibitory factor (MIF) and the P. falciparum–derivedMIF homologue have been reported in patients with ma-
laria.58,59 Recent in vitro studies60 showed that pretreatment
of endothelial cells with MIF induces monocyte arrest
through binding of MIF to the chemokine receptors CXCR2
and CXCR4. The presence of adherent intravascular mono-
cytes could further reduce the already compromised cap-
illary blood flow as a result of iRBC sequestration.
Our findings demonstrate several pathological changes
in the brain in fatal pediatric CM. Some of these changes,
such as brain edema and astrogliosis, appear not to be
specific to malaria and are shared by nonmalarial fatal en-
cephalopathies. Others, including RHs and diffuse axonal
and myelin damage, were seen in children with CM and not
in those who died of a nonmalarial illness. Changes that
were most prominent and distinctive in malaria appeared to
be located within and in the vicinity of blood vessels
containing sequestered iRBCs, platelets, hemozoin pig-
ment, or monocytes. Evidence of both activation and
destruction of the endothelial cells lining microvessels
was prominent among these changes. The most severe
endothelial damage, commonly associated with intralu-
minal thrombosis, manifested as disruption of the vessel
wall, with surrounding RH formation. Myelin and axonal
damage was most evident in proximity to affected mi-
crovessels, suggesting that intravascular and extravas-
cular pathological changes are linked in a causal se-
quence in CM. However, postmortem studies cannot
confidently demonstrate sequence or causality among
topographically associated pathological features, and
further electrophysiological, biochemical, and imaging
studies in prefatal and nonfatal CM are needed to further
our understanding of how malaria causes coma, brain
damage, and death.
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